Infasurf and Alcohol
Infasurf generic name calfactant belongs to the family of drugs which act as ling surface acting agent which help the lung function normally as it is similar to the natural fluid in the lungs that help maintain effective breathing. It is used to treat or prevent respiratory distress syndrome (RDS) in a premature baby whose lungs have not fully developed.
This medication will be administered in a neonatal intensive care unit (NICU) or similar hospital setting. The breathing tube is connected to a ventilator and will remain under constant supervision during treatment and is usually given within 30 minutes of the baby’s birth and is administered every 12 hours for up to a maximum of three doses.
It is necessary that you carefully follow your physician’s instructions about any restrictions in feeding, medications or activity after your baby has been treated with this drug.
There are few side effects but there is the possibility that the baby will have breathing problems while undergoing treatment and these problems may require further treatment as dictated by your physician.
The baby’s caregiver will mange and monitor all drugs given to your baby during treatment in the NCU and a drug interaction between Infasurf and other drus is not expected to occur.
This site serves as an information source only and does not dispense medical advice or any other kind of advice. If you are seeking medical advice you are advised to consult your own physician.
Return from Infasurf and Alcohol to home page.